Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
efficacy and tolerance of a combination of targeted therapies indicated for asthma and chronic inflammatory rheumatism
Original title: “Efficacy and Tolerance of a Combination of Targeted Therapies Indicated for Asthma and Chronic Inflammatory Rheumatism.”
clinical practice and research of chronic inflammatory demyelinating polyneuropathy current status and future
Original title: “[Clinical practice and research of chronic inflammatory demyelinating polyneuropathy: current status and future].”
The discontinuation of Sanofi’s Phase 3 study for its complement inhibitor drug in chronic inflammatory demyelinating polyneuropathy delivers an ‘obviously disappointing’ blow to the broader drug class, according to William Blair.
Original title: “Sanofi cans late-stage study for rare autoimmune disease on underwhelming efficacy”
corrigendum to diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the adhere trial of subcutaneous efgartigimod ph20 journal of the neurological sciences 486 2026 125918
Original title: “Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].”
quality of life in patients with chronic inflammatory demyelinating polyneuropathy
Original title: “Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.”
a case report an 89 year old man taking prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy diagnosed with human herpesvirus 6 variant a encephalitis
Original title: “[A case report: an 89-year-old man taking prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy diagnosed with human herpesvirus 6 variant A encephalitis].”
Original title: “How My CIDP Diagnosis Inspired Me to Give Back”
Original title: “I Won’t Let My CIDP Diagnosis Take Away My Dreams”